Contrast Media Injectors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Contrast Media Injectors Market is segmented By Product, By Type of Injectors (Single-head Injectors, Dual-head Injectors, and Syringeless Injectors), By Application, and Geography.

Market Snapshot

Contrast media injectors Market_1
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The contrast media injectors market studied is anticipated to grow with a CAGR of 6.1%, during the forecast period. The major factors attributing to the growth of the contrast media injectors market are increasing demand for minimally invasive surgeries, and even the technological advancements are helping the market growth along with the increasing number of regulatory approvals.

For instance, there have been several advancements in contrast media injector technology, to reduce contrast media waste and to automate data collection regarding the dose a patient receives. Such as the automated injector systems precisely collects the amount of contrast media used, and vendors have started offering personalized doses for the patients using the information pulled from EMR or PACS. One such advancement in reducing contrast media waste is syringeless injectors.

According to the World Health Organization (WHO), globally cardiovascular diseases (CVDs) are the number one cause of death, an estimated 17.9 million each year suffer from cardiovascular diseases. Four out of five cardiovascular deaths are due to strokes and heart attacks, and one third of deaths occur prematurely in people under 70 years of age.

Most of the companies are developing innovative products to reduce contrast media waste and gain a competitive advantage. Bracco has developed smart syringeless injectors, which are able to use every drop of contrast loaded into the system for maximum economy. The smart injectors record the amount injected and imaging protocol used and send the information to the PACS. These constant technological advancements in the contrast media injector technology are expected to boost the contrast media injector market during the forecast period.

Scope of the Report

As per the scope of the report, contrast media injectors (CMI) are devices employed for injecting contrast media into the body, to improve the visibility of tissues for medical imaging procedures. The contrast media injectors market is segmented by product, type of injectors, application, and geography.

By Products
Injector Systems
CT Injector Systems
MRI Injector Systems
Cardiovascular/Angiography Injector Systems
Other Consumables
By Type of Injectors
Single-head Injectors
Dual-head Injectors
Syringeless Injectors
By Application
Interventional Cardiology
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

CT Injector Systems Segment is Expected to Grow with High CAGR in the Injectors Segment

  • CT injectors are expected to grow positively as the usage of the CT systems has been increasing from the past few years, and these CT systems use a dual-head injector, with two syringes for initial and follow-up contrast doses, during imaging. There has been constant R&D activity by major academic centers and pharmaceutical companies to develop protocols, which helps CT users with the advanced capabilities of newer imaging systems. The integration of IT and contrast media dose management are prospective growth factors for the forecast period.
  • Manufacturers of CT and automated contrast injectors are partnering to better integrate their systems. This includes contrast dose tracking. Mallinckrodt has launched an OptiSync data management system, which is designed to collect and analyze radiology data when a patient undergoes a contrast-media-enhanced CT imaging procedure. 
  • All these factors are expected to help the market to grow positively over the forecast period.
contrast key trend 3.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

  • North America is expected to dominate the overall market, throughout the forecast period. This is due to factors such as increasing preference for minimally invasive procedures and increasing prevalence of chronic diseases owing to changing lifestyles. 
  • As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. 
  • Furthermore, technological advancements in contrast media injectors devices and increasing expenditure by key players along with rising regulatory approvals are also boosting the growth of the contrast media injectors market in North America. In the North America region, the United States holds the largest market share.
Contrast Media Injectors Market2

Competitive Landscape

The contrast media injectors market is consolidated competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. With the increasing technological advancements, high prevalence of diseases and increasing usage of minimally invasive surgeries, more companies are expected to enter into the market in the coming years. Some of the major players of the market are Bracco Group, GE Healthcare, Bayer HealthCare, Medtron AG, and ulrich GmbH & Co. KG are among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Minimally Invasive Surgeries

      2. 4.2.2 Technological Advancements

      3. 4.2.3 Increasing Number of Regulatory Approvals

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Contrast Media Injectors

      2. 4.3.2 Adverse Effects of Contrast Agents

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Products

      1. 5.1.1 Injector Systems

        1. CT Injector Systems

        2. MRI Injector Systems

        3. Cardiovascular/Angiography Injector Systems

      2. 5.1.2 Consumables

        1. Tubing

        2. Syringe

        3. Other Consumables

    2. 5.2 By Type of Injectors

      1. 5.2.1 Single-head Injectors

      2. 5.2.2 Dual-head Injectors

      3. 5.2.3 Syringeless Injectors

    3. 5.3 By Application

      1. 5.3.1 Radiology

      2. 5.3.2 Interventional Cardiology

      3. 5.3.3 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bracco Group

      2. 6.1.2 Guerbet Group

      3. 6.1.3 Medtron AG

      4. 6.1.4 Bayer HealthCare LLC

      5. 6.1.5 ulrich GmbH & Co. KG

      6. 6.1.6 Nemoto Kyorindo Co. Ltd

      7. 6.1.7 GE Healthcare (GE Company)

      8. 6.1.8 Hilin Life Products

      9. 6.1.9 Sino Medical-Device Technology Co. Ltd

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Contrast Media Injectors Market market is studied from 2018 - 2026.

The Contrast Media Injectors Market is growing at a CAGR of 6.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

GE Healthcare (GE Company), Bracco Group, Bayer AG, Medtron AG, ulrich GmbH & Co. KG are the major companies operating in Contrast Media Injectors Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!